My watch list
my.chemeurope.com  
Login  

Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors

Miniaturization and parallel processing play an important role in the evolution of many technologies. We demonstrate the application of miniaturized high-throughput experimentation methods to resolve synthetic chemistry challenges on the frontlines of a lead optimization effort to develop diacylglycerol acyltransferase (DGAT1) inhibitors. Reactions were performed on ∼1 mg scale using glass microvials providing a miniaturized high-throughput experimentation capability that was used to study a challenging SNAr reaction. The availability of robust synthetic chemistry conditions discovered in these miniaturized investigations enabled the development of structure–activity relationships that ultimately led to the discovery of soluble, selective, and potent inhibitors of DGAT1.

Authors:   Tim Cernak; Nathan J. Gesmundo; Kevin Dykstra; Yang Yu; Zhicai Wu; Zhi-Cai Shi; Petr Vachal; Donald Sperbeck; Shuwen He; Beth Ann Murphy; Lisa Sonatore; Steven Williams; Maria Madeira; Andreas Verras; Maud Reiter; Claire Heechoon Lee; James Cuff; Edward C. Sherer; Jeffrey Kuethe; Stephen Goble; Nicholas Perrotto; Shirly Pinto; Dong-Ming Shen; Ravi Nargund; James Balkovec; Robert J. DeVita; Spencer D. Dreher
Journal:   Journal of Medicinal Chemistry
Year:   2017
DOI:   10.1021/acs.jmedchem.6b01543
Publication date:   02-Mar-2017
Facts, background information, dossiers
  • evolution
  • drug discovery
More about American Chemical Society Publications
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE